View More Recent Stories
-
ANI Pharma (ANIP) Announces Proposed Convertible Senior Notes Offering
-
ANI Pharma (ANIP) Announces the FDA Approval and Launch of L-Glutamine Oral Powder
-
ANI Pharma (ANIP) Announces FDA Approval and Launch of Naproxen Delayed-Release Tablets
-
ANI Pharmaceuticals (ANIP) PT Raised to $94 at H.C. Wainwright
-
ANI Pharma (ANIP) Acquires Alimera Sciences (ALIM) for $5.50/sh Cash plus $0.50 CVR
